Alliance Hlthcare Cm (AIQ) 6.23 $AIQ Alliance Oncology

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 2:16 AM

Alliance Hlthcare Cm (AIQ) 6.23 $AIQ

Alliance Oncology Partners with Saint Peter's University Hospital
BusinessWire - Tue Jun 21, 3:57PM CDT
Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today it has completed a partnership agreement with the Saint Peter's University CyberKnife Center, aligning the New Brunswick, New Jersey site with their national network of cancer centers. This agreement is in partnership with Saint Peter's University Hospital and Sovereign Radiation Oncology (local physicians), with Alliance Oncology as the managing member. With Alliance Oncology's proven leadership in evidence-based oncology partnerships, they will bring best in class clinical quality and patient experience to the community, while adding value with their vast network of physician partnerships. Operations commenced on June 1.
AIQ: 6.23 (+0.03)

Luther W. Brady, M.D. Inducted into the Spanish Royal Academy of Medicine
BusinessWire - Wed Jun 15, 6:00AM CDT
Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today that Luther W. Brady, M.D. is being made an Extraordinary International Academic Member of the Spanish Royal Academy of Medicine.
AIQ: 6.23 (+0.03)

Luther W. Brady, M.D. Awarded Seventh Honorary Degree
BusinessWire - Tue Jun 07, 6:00AM CDT
Greg Spurlock, President of Alliance Oncology, announced today that Luther W. Brady M.D., Director of Medical Research at The CyberKnife Center of Philadelphia, is being awarded his seventh honorary degree from Complutense University in Madrid, Spain.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services to Present at LD Micro Invitational and Barclays 2016 High Yield Bond & Syndicated Loan Conferences
BusinessWire - Mon Jun 06, 5:00AM CDT
Alliance HealthCare Services (NASDAQ:AIQ) (the "Company", "Alliance", "we" or "our"

, a leading national provider of outsourced radiology, oncology and interventional services, announced today the results for the quarter ended March 31, 2016.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services to Present at Upcoming B. Riley & Co. Annual Investor Conference
BusinessWire - Thu May 05, 3:18PM CDT
Alliance HealthCare Services (NASDAQ:AIQ) (the "Company", "Alliance", "we" or "our"

, a leading national provider of outsourced radiology, oncology and interventional services, announced today that Tom Tomlinson, Chief Executive Officer and President, and Rhonda Longmore-Grund, Executive Vice President and Chief Financial Officer, will present at the B. Riley & Co. Annual Investor Conference. The presentation will take place on May 26 at 8:30 a.m. to 8:55 a.m. (Pacific Time) at the Loews Hollywood Hotel, 1755 N. Highland Ave., Hollywood, California, 90028. Details related to the Conference can be found at www.brileyco.com.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Schedules Conference Call for First Quarter 2016 Financial Results
BusinessWire - Thu Apr 28, 7:12PM CDT
Alliance HealthCare Services (NASDAQ:AIQ) announced today that it will host a conference call and webcast on Thursday, May 5, 2016, at 5 p.m. Eastern Time, to discuss the Company's first quarter 2016 financial results, which are scheduled to be released after the market closes on Thursday, May 5, 2016. Tom Tomlinson, Chief Executive Officer and President, is scheduled to host the call. Also scheduled to participate is Rhonda Longmore-Grund, Executive Vice President and Chief Financial Officer.
AIQ: 6.23 (+0.03)

Reno CyberKnife Upgrades Their CyberKnife(R) Robotic Radiosurgery System
BusinessWire - Tue Apr 26, 5:27PM CDT
Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced radiology, oncology and interventional services, announced today that one of their radiation therapy centers, Reno CyberKnife, has upgraded their CyberKnife Robotic Radiosurgery System. The decision to upgrade the technology at the center was part of Reno CyberKnife's commitment to ensure patients are treated with the most advanced technology available.
AIQ: 6.23 (+0.03)

Fujian Thai Hot Investment Completes Purchase of a Majority Interest in Alliance HealthCare Services
BusinessWire - Tue Mar 29, 3:05PM CDT
Alliance HealthCare Services, Inc. (NASDAQ: AIQ) (the "Company", "Alliance", "we" or "our"

, a leading national provider of outsourced radiology, oncology and interventional services, announced today that the Company entered into a Governance, Voting and Standstill Agreement (the "Governance Agreement"

with Fujian Thai Hot Investment Co., Ltd ("Fujian Thai Hot"

with respect to the acquisition by Fujian Thai Hot of 5,537,945 shares of common stock of the Company from funds managed by Oaktree Capital Management, L.P. and MTS Health Investors, LLC, and Larry C. Buckelew (together, the "Selling Stockholders"

(the "Transaction"

. Fujian Thai Hot now owns an aggregate of approximately 51.5% of the outstanding common stock of the Company. The Company did not sell any shares in the Transaction.
AIQ: 6.23 (+0.03)

Alliance Oncology Announces Senior Leadership Team Additions and Promotions
BusinessWire - Tue Mar 22, 1:53PM CDT
Alliance Oncology, a division of Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced healthcare services, announced today three new changes to their senior leadership team.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Reports Fourth Quarter & Full Year 2015 Results
BusinessWire - Thu Mar 10, 3:05PM CST
Alliance HealthCare Services, Inc. (NASDAQ: AIQ) (the "Company", "Alliance", "we" or "our"

, a leading national provider of outsourced radiology, oncology and interventional services, announced today the results for the fourth quarter and full year ended December 31, 2015, and provided 2016 guidance.
AIQ: 6.23 (+0.03)

CORRECTING and REPLACING Alliance HealthCare Services Schedules Call to Report Fourth Quarter and Full Year 2015 Financial Results and 2016 Financial Guidance
BusinessWire - Thu Mar 03, 6:56PM CST
Headline of release should read: Alliance HealthCare Services Schedules Call to Report Fourth Quarter and Full Year 2015 Financial Results and 2016 Financial Guidance (instead of Alliance HealthCare Services Reports Fourth Quarter and Full Year 2015 Financial Results and Releases 2016 Financial Guidance).
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Reports Fourth Quarter and Full Year 2015 Financial Results and Releases 2016 Financial Guidance
BusinessWire - Thu Mar 03, 6:05PM CST
Alliance HealthCare Services (NASDAQ:AIQ) announced today that it will host a conference call and webcast on Thursday, March 10, 2016 at 5 p.m. Eastern Time to discuss the Company's fourth quarter and full year 2015 financial results and 2016 financial guidance, which are scheduled to be released after the market closes on Thursday, March 10, 2016. Tom Tomlinson, Chief Executive Officer and President, is scheduled to host the call. Also scheduled to participate is Howard K. Aihara, Executive Vice President and Chief Financial Officer.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Provides Update on Stockholder Transaction
BusinessWire - Wed Jan 06, 4:25PM CST
--Majority of requirements cleared to successfully close the transaction
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Shares Down 35.2% Since SmarTrend's Sell Call (AIQ)
Comtex SmarTrend(R) - Tue Nov 17, 10:04AM CST
SmarTrend identified a Downtrend for Alliance HealthCare Services (NYSE:AIQ) on September 18th, 2015 at $12.34. In approximately 2 months, Alliance HealthCare Services has returned 35.17% as of today's recent price of $8.00.
AIQ: 6.23 (+0.03)

22.2% Return Seen to Date on SmarTrend Alliance HealthCare Services Call (AIQ)
Comtex SmarTrend(R) - Tue Nov 10, 9:24AM CST
SmarTrend identified a Downtrend for Alliance HealthCare Services (NYSE:AIQ) on September 18th, 2015 at $12.34. In approximately 2 months, Alliance HealthCare Services has returned 22.20% as of today's recent price of $9.60.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Reports Third Quarter 2015 Results
BusinessWire - Thu Nov 05, 3:04PM CST
Alliance HealthCare Services, Inc. (NASDAQ:AIQ) (the "Company," "Alliance," "we" or "our"

, a leading national provider of outsourced diagnostic imaging through its Alliance HealthCare Radiology Division ("Alliance Radiology"

, interventional radiology & pain management services through its Interventional Services Division ("Alliance HealthCare Interventional Partners"

and radiation therapy services through its Alliance HealthCare Oncology Division ("Alliance Oncology"

, today announced the results for the third quarter and nine months ended September 30, 2015.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Announces New Partnership with Premier Florida Interventional Pain Management Care Provider
BusinessWire - Wed Nov 04, 9:57PM CST
Alliance HealthCare Services, Inc. (NASDAQ:AIQ), a leading national provider of outsourced radiology, oncology and interventional services, announces a new joint venture partnership with PRC Associates, LLC ("PRC"

. PRC is a premier provider of interventional pain management services in Florida, delivered at eight locations in Central Florida and the Palm Coast.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Has Returned 25.4% Since SmarTrend Recommendation (AIQ)
Comtex SmarTrend(R) - Mon Nov 02, 5:09PM CST
SmarTrend identified a Downtrend for Alliance HealthCare Services (NYSE:AIQ) on September 18th, 2015 at $12.34. In approximately 2 month, Alliance HealthCare Services has returned 25.45% as of today's recent price of $9.20.
AIQ: 6.23 (+0.03)

Alliance HealthCare Services Schedules Conference Call for Third Quarter 2015 Financial Results
BusinessWire - Fri Oct 30, 12:59PM CDT
Alliance HealthCare Services, Inc. (NASDAQ:AIQ) announced today that it will host a conference call and webcast on Thursday, November 5, 2015, at 5:00 p.m. Eastern Time, to discuss the Company's third quarter 2015 financial results, which are scheduled to be released after the market closes on Thursday, November 5, 2015. Tom Tomlinson, Chief Executive Officer and President, is scheduled to host the call. Also scheduled to participate is Howard K. Aihara, Executive Vice President and Chief Financial Officer.
AIQ: 6.23 (+0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...